… drug to tackle burden of kala-azar, also known as visceral leishmaniasis … expected to change the treatment paradigm for life-threatening … against the Chikungunya virus, developed in his lab. Prof. … The Institute is also developing rapid antigen tests for …

… which is crucial for treating parasitic infections. The … ability to develop resistance to drugs. Current treatments are often … treatment of leishmaniasis and sleeping sickness by improving drug … with Drugs. Journal of Exploratory Research in Pharmacology. doi …

… in 2014 by the FDA and is indicated for … when treating cutaneous leishmaniasis is that the drugs used to treat the … treatment for cutaneous leishmaniasis. However, according to the CDC, these medications … are not approved by the Food and Drug …

… , particularly in poorer and developing areas. It can cause … Leishmaniasis: Treatment depends on the type and severity of the disease: Antiparasitic Medications: Medications … leishmaniasis. Topical Treatments: Creams like Paromomycin are used to treat …

… treat colorectal inflammation. Advanced targeted nanomaterial drug delivery systems (NDDS) have been developed … drugs in colorectal cancer. Annu Rev Med … for treating inflammatory bowel … drug loaded vehicle for the topical treatment of cutaneous leishmaniasis …

… M worth investment for developing diagnostics and drugs for malaria, NTDs January … critical diagnostic tool to combat Leishmaniasis image credit- shutterstock The Global … million) for the development of a malaria therapeutic drug through a partnership …

… patients. “When I subsequently developed symptoms such as leg and … services including screening, diagnosis, treatment, health education, and patient … healthcare, primary healthcare, treatment for cutaneous leishmaniasis (CL), drug-resistant tuberculosis (DR- …

… reached 21 hours. Pharmacokinetic studies measuring the … in the treatment of visceral leishmaniasis. With these … compound to produce medications against visceral leishmaniasis, but a … in developing drugs for neglected diseases such as visceral leishmaniasis. …

… the development of new diagnostics and drugs for … b (Bangladesh) Disease Leishmaniasis Intervention Diagnostics Stage Pre- … Drug Administration (US FDA) for a proof-of-concept clinical trial … of selected confirmed treatments against lymphocytic choriomeningitis …

… treatment received (antibiotic, antiTB drugs, chemotherapy, etc), and treatment duration … infectious mononucleosis and leishmaniasis were identified in … concomitant existence, diagnosing, treating, and managing LAPs … in a developing country. Pan Afr Med J. …